In non-small-cell lung cancer, NLRC5 seems to be a negative indicator of prognosis (63), whereas in other types such as endometrial cancer and melanoma, NLRC5 downregulation has been correlated with poor prognosis (20, 64, 65). This evidence concerns the gene NLRC5 and endometrial cancer.